[go: up one dir, main page]

DK0545991T3 - Peptider, der blokerer infektioner med human immundefektvirus, og fremgangsmåder til anvendelse deraf - Google Patents

Peptider, der blokerer infektioner med human immundefektvirus, og fremgangsmåder til anvendelse deraf

Info

Publication number
DK0545991T3
DK0545991T3 DK91915038T DK91915038T DK0545991T3 DK 0545991 T3 DK0545991 T3 DK 0545991T3 DK 91915038 T DK91915038 T DK 91915038T DK 91915038 T DK91915038 T DK 91915038T DK 0545991 T3 DK0545991 T3 DK 0545991T3
Authority
DK
Denmark
Prior art keywords
peptides
methods
immunodeficiency virus
human immunodeficiency
virus infections
Prior art date
Application number
DK91915038T
Other languages
English (en)
Inventor
Anders Vahlne
Bo Svennerholm
Stig Jeansson
Peter Horal
Lars Rymo
Original Assignee
Tripep Ab
Syntello Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tripep Ab, Syntello Inc filed Critical Tripep Ab
Application granted granted Critical
Publication of DK0545991T3 publication Critical patent/DK0545991T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/28—Materials for coating prostheses
    • A61L27/34—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • C07K5/06165—Dipeptides with the first amino acid being heterocyclic and Pro-amino acid; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/0806—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1019—Tetrapeptides with the first amino acid being basic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Transplantation (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK91915038T 1990-08-22 1991-08-20 Peptider, der blokerer infektioner med human immundefektvirus, og fremgangsmåder til anvendelse deraf DK0545991T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US57108090A 1990-08-22 1990-08-22
PCT/SE1991/000544 WO1992003147A1 (en) 1990-08-22 1991-08-20 Peptides that block human immunodeficiency virus infections and methods of use thereof

Publications (1)

Publication Number Publication Date
DK0545991T3 true DK0545991T3 (da) 1999-08-16

Family

ID=24282265

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91915038T DK0545991T3 (da) 1990-08-22 1991-08-20 Peptider, der blokerer infektioner med human immundefektvirus, og fremgangsmåder til anvendelse deraf

Country Status (17)

Country Link
EP (1) EP0545991B1 (da)
JP (1) JP3115596B2 (da)
KR (1) KR100220531B1 (da)
AT (1) ATE173934T1 (da)
AU (1) AU667290B2 (da)
BR (1) BR9106772A (da)
CA (1) CA2088788C (da)
DE (1) DE69130571T2 (da)
DK (1) DK0545991T3 (da)
ES (1) ES2128322T3 (da)
FI (1) FI930519L (da)
GR (1) GR3029523T3 (da)
HU (1) HUT63177A (da)
MC (1) MC2306A1 (da)
NO (1) NO930401L (da)
OA (1) OA10051A (da)
WO (1) WO1992003147A1 (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100168038A1 (en) * 2006-01-13 2010-07-01 Rickard Glas Use of compounds in combination with gamma-irradiation for the treatment of cancer
FR2925500B1 (fr) * 2007-12-21 2011-05-06 Vincience Peptide derive d'une proteine de la famille des aquaporines et composition cosmetique et/ou pharmaceutique le contenant
FR2925501B1 (fr) * 2007-12-21 2012-12-14 Vincience Peptide activateur de la synthese des aquaporines et composition cosmetique et/ou pharmaceutique le contenant

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63501716A (ja) * 1985-10-24 1988-07-14 サウスウエスト・ファウンデ−ション・フォア・バイオメディカル・リサ−チ 合成ペプチドおよびａｉｄｓおよびａｒｃの診断ならびにワクチン注射へのその使用
NL8702403A (nl) * 1987-10-09 1989-05-01 Stichting Centr Diergeneeskund Oligopeptiden en gebruik daarvan voor diagnostische en vaccinatiedoeleinden voor aids en arc.

Also Published As

Publication number Publication date
JP3115596B2 (ja) 2000-12-11
CA2088788C (en) 2003-12-16
NO930401L (no) 1993-02-17
FI930519L (fi) 1993-04-21
ES2128322T3 (es) 1999-05-16
AU667290B2 (en) 1996-03-21
CA2088788A1 (en) 1992-02-23
HUT63177A (en) 1993-07-28
DE69130571T2 (de) 1999-06-17
AU8433291A (en) 1992-03-17
WO1992003147A1 (en) 1992-03-05
FI930519A0 (fi) 1993-02-05
BR9106772A (pt) 1993-07-20
NO930401D0 (no) 1993-02-05
GR3029523T3 (en) 1999-06-30
EP0545991A1 (en) 1993-06-16
MC2306A1 (fr) 1993-09-27
OA10051A (en) 1996-10-14
KR100220531B1 (ko) 1999-10-01
HU9300456D0 (en) 1993-05-28
JPH06504035A (ja) 1994-05-12
DE69130571D1 (de) 1999-01-14
EP0545991B1 (en) 1998-12-02
ATE173934T1 (de) 1998-12-15

Similar Documents

Publication Publication Date Title
TR199903053T2 (xx) Benzimidazol t�revleri.
DE69632256D1 (de) Antivirale proteine, dafür kodierende dna, und deren verwendung
NO20020571L (no) Peptider som blokkerer infeksjonsevnen, og fremgangsmåter for anvendelse av disse
UA66744C2 (en) 5,6-dichlorobenzimidazole derivatives, methods for the preparation thereof, pharmaceutical composition and method for treatment of viral infections
UA29429C2 (uk) Фармацевтична композиція для лікування вірусних інфекцій, спосіб отримання композиції, спосіб лікування або профілактики віл-інфекції у людини
DE69929232D1 (de) Virusähnliche partikel zur induktion von autoantikörpern
DK169986A (da) Antigen beslaegtet med glycoproteinet i aids-virus, isaer en praekursor for glycoproteinet, og fremgangsmaade til fremstilling af et saadant antigen
NO912825D0 (no) Fremgangsmaate for fremstilling av cokonjugate vaksiner omfattende immunogenisk protein, hiv-beslektede peptider og anioniske grupper.
EP0306219A3 (en) Novel hiv proteins and peptides useful in the diagnosis, prophylaxis or therapy of aids
EA199800526A1 (ru) Производные бензимидазола и их применение для лечения вирусных инфекций
DK0545991T3 (da) Peptider, der blokerer infektioner med human immundefektvirus, og fremgangsmåder til anvendelse deraf
PL326629A1 (en) Application of flupyrtin in prophylaxy and therapy of deseases associated with damaged hematopoietic cellular system
AU2880595A (en) Use of pharmaceutical agents for restoring, alleviation, or treatment of immunodeficiency, including the alleviation or treatment of the immune dysfunction related to infection with human immunodeficiency viruses (hiv) or related viruses
DK0491713T3 (da) Rubella El-peptider og C-peptider
ATE108335T1 (de) Kit oder zusammensetzung zur vorbeugung oder behandlung von hiv-1 infektionen.
UA41338C2 (uk) Спосіб інгібування ретровірусної інфекції, яка викликана вірусом імунодефіциту людини (віл), спосіб інгібування вірусу імунодефіциту людини (віл)
HUP0100937A2 (hu) Többszörösen elágazó peptidkonstrukciókat tartalmazó liposzómák és alkalmazásuk humán immundeficiencia vírus ellen
RU93005034A (ru) Пептиды, блокирующие инфекцию вируса иммунодефицита человека, способы их применения
EP0247873A3 (en) Bacteriocins and compositions thereof in anti-viral treatment
EA199700353A1 (ru) Композиция и способ для определения приобретенного синдрома иммунодефицита, способ приготовления названной композиции
EP1143981A4 (en) TREATMENT AND PREVENTION OF HIV AND OTHER VIRUS INFECTIONS
HRP20030701A2 (en) Natural antibodies active against hiv virus
AU2880495A (en) Use of pharmaceutical agents for alleviation or treatment of the immune dysfunction related to infection with human immunodeficiency viruses (hiv) or related viruses
ES8605576A1 (es) Un procedimiento para preparar una composicion contra infecciones virales de hepatitis b
AU6592990A (en) Prevention of glycoprotein enveloped virus infectivity by quinolyloxazole-2-ones